This page is ZOH's public ledger: every important grade we have given — to the products on our shelf, to our own plans, and to ourselves — published with the reason it moved, and filed under sixteen subjects.
WE DON'T BELIEVE IT. WE MEASURE IT.
When a public claim about something that happened in the world needs measuring, the court's ruling files here.
No verdicts filed yet. This bench is empty on purpose — the court does not invent a ruling to fill a page. When a world-event claim gets measured, its verdict lands here, with its date and its expiry.
The evidence itself, ruled on: what the studies actually showed, at the doses actually studied — and what happened when we pointed the same standard at ourselves.
Three measurements did most of the work in our shelf audit. They are printed here — with the rule they produced — because the grades under Products answer to them:
Before this court graded anything for anyone else, it graded the agent that runs ZOH's operations — on one full day of its work. The panel checked the day's reported numbers against the underlying records; every tally, price, and verdict verified. The B rests on three reporting errors, all self-caught and corrected in the open: a link described as serving a corrected build before the correction was actually live; a morning-brief line that was wrong and fixed within minutes; and a "queue clear" message sent while three jobs were still running. The errors were ours. So is the grade. It is printed here, unedited, because a court that won't publish its own operator's B has no business publishing yours.
One case so far — the biggest one we could pick. Graded on two scores that are never merged into one.
✓ Verdict filed · Oct 25, 2026
The court graded the world's major religions — on evidence. Ten traditions were each measured the same way: the checkable claims at their core (a founder's existence, a text's dating, an event's corroboration) weighed against the independent record — manuscripts, archaeology, sources outside the tradition. That produced an evidence score. Separately, each tradition's documented community record — its antiquity, its continuity, what its practitioners' lives actually show — produced a lean-on score. The two scores are reported side by side and never merged: there is no single winner, by design. Claims that cannot be tested were stamped untestable and excluded from the evidence score entirely. Grades expire January 23, 2027.
How much of each tradition's checkable core survives outside scrutiny. No tradition in the field earned an A on evidence — every one's central claims include a substantial contested or uncorroborated share. The leaders are the youngest, most densely documented traditions in the field: a 19th-century faith documented by contemporary newspapers and court records, and a tradition with dated manuscripts and an extensive written record. That is a fact about documentation density, printed on the face so the ranking is never quoted as more than it is — the older the tradition, the thinner the surviving independent record, everywhere, without exception. Grades also weight how central a claim is, not just the count: two grades sit below their supported share because the claims without corroboration are among the most central.
| Tradition | Grade | Supported | Contested | No corroboration |
|---|---|---|---|---|
| Baháʼí Faith | B | 76% | 14% | 10% |
| Sikhism | B | 75% | 17% | 8% |
| Buddhism | B | 61% | 21% | 18% |
| Christianity | B | 61% | 20% | 19% |
| Islam | C | 57% | 22% | 21% |
| Hinduism | C | 54% | 13% | 33% |
| Zoroastrianism | C | 49% | 29% | 22% |
| Judaism | C | 48% | 21% | 31% |
| Jainism | C | 43% | 25% | 32% |
| Taoism | C | 43% | 21% | 36% |
How well each tradition holds up for the people who actually live by it: antiquity and continuity, the documented record of its community, and practitioner outcomes weighed for evidence quality.
| Tradition | Grade |
|---|---|
| Judaism | A |
| Christianity | A |
| Buddhism | A |
| Islam | B |
| Hinduism | B |
| Sikhism | C |
| Baháʼí Faith | C |
| Taoism | C |
| Jainism | C |
| Zoroastrianism | C |
Judaism is the lean-on outlier — three-plus millennia of documented continuity through exile, diaspora, and catastrophe; it took the top grade in every round. One grade here must never be quoted bare: the Baháʼí Faith's C. Its ballots ranged from A to D — the widest split in the field — because this axis's antiquity measure structurally caps a community only about 180 years old. Its C is partly a property of the measuring stick, and it is recorded as such.
Every tradition's claims were counted, and the share that no evidence can settle was stamped, not scored. The quiet finding of the whole case: the metaphysical core is roughly the same relative size everywhere — what differs is how the checkable remainder fares.
| Tradition | Untestable share |
|---|---|
| Baháʼí Faith | 25.0% — the field's lowest |
| Zoroastrianism | 27.8% |
| Hinduism | 28.6% |
| Buddhism | 28.6% |
| Jainism | 29.4% |
| Taoism | 29.4% |
| Christianity | 31.8% |
| Islam | 31.8% |
| Judaism | 31.8% |
| Sikhism | 33.3% — the field's highest |
What this verdict is not. Absence of evidence was recorded as absence — never as disproof. The court graded the checkable remainder and the documented record, nothing else. It did not, and cannot, grade the truth of anyone's faith.
What you can buy, graded as sold. The rule every grade in this section answers to is printed first — and it has already cost us products we were selling.
ZOH sells nothing graded below C. Every product is graded as sold — the exact dose, form, and label you can buy — against the published scientific evidence. When the evidence drops a product, the product goes, even if it was selling. If we can't verify what's in the bottle, it doesn't stay on the shelf.
Five grades of A survive a hostile reading of the evidence. Full audit: October 13, 2026. An inflated A is a failure, not a win — two of our own A's fell in this audit (below).
The most-studied supplement in sports science, graded at exactly the form and dose sold (5 g/day). Across hundreds of trials it improves lean mass and strength on top of training — and the effect is null without training. So the claim stays welded to training, and the grade stays A. If our copy ever promised muscle for people who don't train, this grade would drop.
Three independent, regulator-recognized evidence domains: LDL cholesterol down ~13 mg/dL across 28 randomized trials; blood-sugar control in type 2 diabetes approaching a full HbA1c point in meta-analysis; and an FDA-authorized heart-health claim. The A belongs only to a product that actually delivers the studied dose — a couple of capsules a day is a different, weaker product.
The hardest outcome any supplement has ever been shown to move: neural tube birth defects, prevented in randomized trials — a 72% reduction in recurrence in the landmark MRC trial. The US Preventive Services Task Force issues its own Grade A recommendation for folic acid before and during early pregnancy. The A travels with that scoped claim, not with the molecule in general.
Performance is the rare claim where the outcome measured is the outcome sold. At 3–6 mg per kilo of body weight, caffeine improves endurance, strength, and sprint performance in essentially every rigorous synthesis ever run — about +2.9% mean power in endurance time trials, where 2% is the difference between the podium and the pack. The A requires a label that honestly reaches that dose.
Home blood-pressure monitoring carries the US Preventive Services Task Force's own Grade A recommendation, and validated cuffs sit on a public accuracy registry. We stock only registry-listed models, in the right cuff size. That registry is the difference between an A product and a gadget.
Same audit, October 13, 2026. These were our grades, on our shelf — and the evidence said lower.
The A rested on a blood marker: D3 reliably raises vitamin D levels. But at the dose sold, in largely vitamin-D-replete adults, the big outcome trials are null — VITAL (25,871 people) found no reduction in cancer or major cardiovascular events, and its fracture study found no benefit either. The clear outcome signal is concentrated in people who are actually deficient. Honest grade: B — it corrects and maintains vitamin D status; outcome benefits are proven mainly in deficiency.
The famous trial behind fish oil's reputation tested a prescription drug at roughly 13 times this dose, in high-risk patients. The comparable high-dose trial with a neutral comparison failed outright, and the pooled record at supplement doses is null — including a 10-trial, 77,917-person analysis finding no association with heart death or heart attack. Graded as sold, there is no demonstrated meaningful effect. C, with the caveat printed wherever it appears.
Human trials so far are small and short, and they move a blood marker — NAD+ levels — not a health outcome anyone can feel or measure in their life. A biomarker is not a benefit. C until an adequately powered trial moves a real functional or clinical endpoint.
Our supplier could not produce a certificate of analysis for what was in the bottle — and the label's own math delivered roughly 73 mg of active berberine per serving, against studied doses of 900–1,500 mg a day. Evidence at many times the as-sold dose is not evidence for this product. Berberine came off the shelf, and the seven bundles containing it came down with it. The full public note, with the label it was sold under, stands at zohhealth.com/p/berberine/.
Ruled October 12, 2026, under the same law: graded as sold, proven-but-modest is a B, ties go lower.
Grade B: home AED · over-the-counter CGM · electric toothbrush · digital thermometer.
Grade C: pill cutter · TENS unit · CPAP filters · smart scale.
The validated blood pressure monitor (Grade A, above) is the shelf's only A device — a public validation registry exists for cuffs; none exists for thermometers. That registry is the difference.
The prescription side of ZOH. This section's cupboard is thin today, and we say so on the page rather than padding it — what stands here is posture, printed in the open, while the first graded verdicts are in session.
The full intended prescription shelf is published at zohhealth.com/rx/ — every row an FDA-approved product or a lawful 503A compound. The gray market is excluded by law, not by preference: compounded copycat products, custom blend bottles, and interim-listed substances do not appear, at any price. And nothing on that shelf is sold today. Each doorway carries its gate in the open, and a doorway opens only when its gate closes in full — licensed clinical partner, pharmacy, counsel check, insurance, state licensure, and the founders' activation, in that order, with no partial passes. The court's ruling on the whole arm stands until then: a show, not a store.
Where this arm practices, eligibility and progress are decided by measured lab work — before a program starts, and again while it runs. A questionnaire is a claim about a person. A lab is a measurement of one. When the two disagree, the lab wins, and the change is recorded.
First graded verdicts in session. When a medicine is graded here — a program, a protocol, a claim — its verdict files in this section, with its date and its expiry.
The measured-life wing — sleep, routines, habits, food, movement, rest, recovery. The things of a life, graded the same way as everything else here. Don't forget to live; measure how it goes.
● Now in session
The founder's own sleep, on trial — SLEEP-ANCHOR-1. One person, one change, measured properly: a fixed 9:30 PM anchor (21:30 ET), tested against his own baseline in four alternating 7-night blocks, starting November 12, 2026. The bars were set before the first night, not after: an average gain of 0.30 hours or more is a hit; a loss of 0.30 hours or more is a harm; anything between is noise, and noise gets reported as noise. The protocol was filed October 13, 2026. No results exist yet, and none will be hinted at — the verdict lands here when the blocks are measured.
First public verdicts file here. Routines, habits, rest, recovery — when a claim about living gets measured, its verdict publishes in this section.
Prices and fees, put on trial — and the only question that matters after the evidence: was it worth it?
● Now in session
The first worth-it verdicts are being graded. A slate of high-priced health products — each graded as sold first, then judged against its price and against the standard option it claims to beat — is before the court. When the verdicts file, they publish here, prices and all.
AI tools and software claims, graded as sold — including the tools we grade for ourselves before we let them near our work.
7 adopted · 11 sent to trial · 2 rejected. One rejection was outright, flagged by 15 of 15 ballots: a tool that would have sent our members' voices to an outside company's cloud. Privacy is a grade too. And the slate's overall C? It was dragged down by the evidence behind the tools' own claims — several headliner claims rested on unverified vendor evidence. The court's answer was to adopt the cheap, measurable ones as small tests instead of big commitments. That is what a C is for.
Foods, labels, and diet claims — what the package says versus what the evidence says. (Bottled supplements file under Products.)
No verdicts filed yet. The first label that gets measured files here.
Training methods and programs — what you do. (What you buy for it files under Products.)
No verdicts filed yet. When a method's promise gets measured against its evidence, the verdict lands here.
Focus tools, desks, glasses, and productivity claims — the equipment and promises of the working day, graded as sold.
No verdicts filed yet. The first productivity claim that gets measured files here.
Meditation apps, sleep aids, and mental-health claims. Claims here are graded as claims — a measured claim is not care, and this page never pretends otherwise.
No verdicts filed yet. When a mind claim gets measured, its verdict lands here — as a claim, with its evidence, and its limits printed.
Pet health products and claims. The animal can't read the label — so the label gets read twice as hard.
No verdicts filed yet. The first pet claim that gets measured files here.
Jet lag, altitude, and travel-health claims — the remedies sold to people far from home, graded as sold.
No verdicts filed yet. When a travel claim gets measured, its verdict lands here.
Air, water, light — the health of the house itself, and the devices that claim to improve it.
No verdicts filed yet. The first home claim that gets measured files here.
Every ruling, in the order it fell — the chronological strip under the subjects above. Outcomes only, and every grade carries its date.
| Date | Decision | Outcome |
|---|---|---|
| Oct 13, 2026 | The Grade-A audit of our own shelf | 5 A's stand. Vitamin D3 A→B · Omega-3 A→C · NMN B→C. Two of the A's we started the day with were borrowed evidence; they fell. |
| Oct 18, 2026 | The panel grades its own operator | GRADE B Three reporting errors found, corrected in the open, printed under Science. |
| Oct 21, 2026 | Berberine | PULLED Supplier could not verify contents; as-sold dose was a fraction of the studied dose. 8 products archived, including 7 bundles. |
| Oct 25, 2026 | The Christmas plan — the founder's direction, put to the court against three alternatives | GRADE B The founder's direction upheld: best on 12 of 16 blind ballots; approved 16 of 16 with conditions after deliberation. One seat's dissent stands on the record: it would grade each film during the sprint instead of in a separate phase, and it questions the division-first order. The dissent is printed, not buried. Expires Jan 23, 2027. |
| Oct 25, 2026 | The next-generation tools slate — 20 candidate tools, voted blind | GRADE C 7 adopted · 11 sent to trial · 2 rejected. One rejection was outright, flagged by 15 of 15 ballots: a tool that would have sent our members' voices to an outside company's cloud. Privacy is a grade too. Full card under AI & Technology. Expires Jan 23, 2027. |
| Oct 25, 2026 | The world's religions, graded on evidence | Two scores, never merged. Evidence: Baháʼí Faith and Sikhism lead at GRADE B — no A on evidence anywhere. Lean-on: GRADE A to Judaism, Christianity, and Buddhism. Untestable share: 25–33% in every tradition. Full verdict under Religion. Expires Jan 23, 2027. |
How to read this page. A grade here is a measurement, not a mascot. It has a date, a reason, and an expiry. When a grade changes, the old one stays in the ledger with the reason it moved — the record is the product.
ZOH · Don't Forget to Live
The Court Record · Published October 25, 2026 · Grades are re-measured when the evidence moves.